Journal article icon

Journal article

Effect of maternal vitamin D supplementation on nasal pneumococcal acquisition, carriage dynamics and carriage density in infants in Dhaka, Bangladesh

Abstract:
BACKGROUND: Invasive pneumococcal disease is a major cause of infant morbidity and death worldwide. Vitamin D promotes anti-pneumococcal immune responses in vitro, but whether improvements in infant vitamin D status modify risks of nasal pneumococcal acquisition in early life is not known. METHODS: This is a secondary analysis of data collected in a trial cohort in Dhaka, Bangladesh. Acute respiratory infection (ARI) surveillance was conducted from 0 to 6 months of age among 1060 infants of women randomized to one of four pre/post-partum vitamin D dose combinations or placebo. Nasal swab samples were collected based on standardized ARI criteria, and pneumococcal DNA quantified by qPCR. Hazards ratios of pneumococcal acquisition and carriage dynamics were estimated using interval-censored survival and multi-state modelling. RESULTS: Pneumococcal carriage was detected at least once in 90% of infants by 6 months of age; overall, 69% of swabs were positive (2616/3792). There were no differences between any vitamin D group and placebo in the hazards of pneumococcal acquisition, carriage dynamics, or carriage density (p > 0.05 for all comparisons). CONCLUSION: Despite in vitro data suggesting that vitamin D promoted immune responses against pneumococcus, improvements in postnatal vitamin D status did not reduce the rate, alter age of onset, or change dynamics of nasal pneumococcal colonization in early infancy. Trial registration Registered in ClinicalTrials.gov with the registration number of NCT02388516 and first posted on March 17, 2015
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5116-9998
More by this author
Role:
Author
ORCID:
0000-0002-4103-4835
More by this author
Role:
Author
ORCID:
0000-0002-2801-723X
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3116-2593


More from this funder
Funder identifier:
10.13039/100000865
Grant:
OPP1066764


Publisher:
BioMed Central
Journal:
BMC Infectious Diseases More from this journal
Volume:
22
Issue:
1
Pages:
52-52
Article number:
52
Publication date:
2022-01-13
DOI:
EISSN:
1471-2334
ISSN:
1471-2334


Language:
English
Keywords:
Pubs id:
1236840
Local pid:
pubs:1236840
Source identifiers:
W4206156708
Deposit date:
2026-04-09
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP